• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biohaven Ltd (NY: BHVN )

    39.70 -0.48 (-1.21%)
    Streaming Delayed Price Updated: 10:16 AM EDT, May 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 69,362
    Open 40.18
    Bid (Size) 39.62 (4)
    Ask (Size) 39.77 (4)
    Prev. Close 40.18
    Today's Range 39.21 - 40.86
    52wk Range 12.96 - 62.21
    Shares Outstanding 65,401,228
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
    These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May. 
    Via InvestorPlace
    Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying
    Via Benzinga

    Performance

    YTD
    -5.33%
    -5.33%
    1 Month
    -23.75%
    -23.75%
    3 Month
    -10.76%
    -10.76%
    6 Month
    +34.60%
    +34.60%
    1 Year
    +200.72%
    +200.72%

    More News

    Read More
    3 Biotech Stocks to Buy on the Dip: April 2024
    Via InvestorPlace
    Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday?
    Via Benzinga
    Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly
    Via Benzinga
    Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/8
    Via Investor Brand Network
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/4
    Via Investor Brand Network
    Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
    Via Investor's Business Daily
    This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
    Via Benzinga
    Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
    Via InvestorPlace
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 1/5
    Via Investor Brand Network
    Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
    Via Investor's Business Daily
    FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Based on good technical signals, BIOHAVEN LTD is potentially setting up for a breakout.
    Via Chartmill
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Sets New 52-Week High in Monday Session
    Via Investor Brand Network
    Biohaven Ltd. (NYSE: BHVN) Records 52-Week High Thursday Morning
    Via Investor Brand Network
    Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review
    Via Investor's Business Daily
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    What's Going On Pfizer's Subsidiary Biohaven Stock?
    Via Benzinga
    Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Biohaven, Yet Another Argenx Rival In Autoimmune Drugs, Just Rocketed 29%
    Via Investor's Business Daily
    Why Biohaven Stock Is Skyrocketing Today
    Via The Motley Fool
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Leading the Way in Wednesday Trading Based on Percentage Gain
    Via Investor Brand Network
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.